Evidence map›Paper›PMID 40362510›Full record

SynthesisInternational journal of molecular sciences2025

Biotechnological Applications of Biogenic Nanomaterials from Red Seaweed: A Systematic Review (2014-2024).

Aline Nunes, Graziano Rilievo, Massimiliano Magro, Marcelo Maraschin, Fabio Vianello, Giuseppina Pace Pereira Lima

Abstract readSystematic Review
In one paragraph

Synthesis in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aline NunesDepartment of Chemical and Biological Sciences, Institute of Biosciences, São Paulo State University, Botucatu 18618-970, São Paulo, Brazil.ORCID 0000-0002-7758-2681
Graziano RilievoDepartment of Comparative Biomedicine and Food Science, University of Padova, Viale dell'Università 16, 35020 Legnaro, Padua, Italy.ORCID 0000-0003-4098-5636
Massimiliano MagroDepartment of Comparative Biomedicine and Food Science, University of Padova, Viale dell'Università 16, 35020 Legnaro, Padua, Italy.ORCID 0000-0002-4644-004X
Marcelo MaraschinDepartment of Plant Science, Federal University of Santa Catarina, Florianópolis 88034-000, Santa Catarina, Brazil.
Fabio VianelloDepartment of Comparative Biomedicine and Food Science, University of Padova, Viale dell'Università 16, 35020 Legnaro, Padua, Italy.ORCID 0000-0002-4874-7205
Giuseppina Pace Pereira LimaDepartment of Chemical and Biological Sciences, Institute of Biosciences, São Paulo State University, Botucatu 18618-970, São Paulo, Brazil.

Funding

National Council for Scientific and Technological Development, Brazil (CNPq). 311719/2023-6São Paulo Research Foundation (FAPESP) 2023/03886-1
6 · The paper itself

Abstract

Green synthesized nanoparticles (NPs) are arousing constantly increasing attention due to inherent advantages such as biocompatibility, nontoxicity, and cost-effectiveness. As the state of the art of this rapidly evolving topic demands a punctual update, the present study was focused on reviewing the novelty, feasibility, and effectiveness related to the specific category of red seaweed-derived NPs. Among algae, red seaweeds have already gained consideration in the global market due to their high content of primary and secondary metabolites, supporting multifunctional applications across various industries. This scoping review reveals how this interest has also driven their investigation as a natural source for the sustainable NP fabrication. The fragmentary body of studies was synthesized, identifying red seaweed NPs as a flourishing nanotechnological subgroup and meriting their own space in the scientific literature. Noteworthy, the great majority of the reviewed papers feature efficient controlled release, enhanced bioavailability, and reduced toxicity, making red seaweed NPs elective candidates for the medical sector as anticancer, antimicrobial, and antioxidant agents. Moreover, their parent natural counterparts seem to endow NPs with unexpected specificity toward biological targets such as prokaryotic and tumor cells. Nanotechnological solutions based on red seaweeds pave the way to a new avenue of opportunities and challenges.

Indexed as

BiotechnologyNanostructuresRhodophytaSeaweedAnimalsAntioxidantsHumansNanoparticlesAntioxidantsbio-coronascropsnanotechnologyRhodophytatherapeutics

Identifiers

PMID40362510
PMCPMC12072177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.